Redeye is encouraged by the continued good organic growth trend. The gross margin continued to improve even if some of the challenges in the market were still present during the quarter. We made minor changes to our estimates as the report was much in line with expectations. The company’s current valuation is very low and not considering much of its potential. We reiterate our Base case of SEK 30 per share.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Tagmaster - Valuation not reflecting the potential

© Modular Finance, source Nordic Press Releases